编排智能疗法以实现小细胞肺癌的最佳治疗:最近的进展和未来的方向
Chenyue Zhang1, Chenxing Zhang2, Kai Wang3
1Department of Integrated Therapy, Fudan University Shanghai Cancer Center, Shanghai Medical College, Shanghai, China.
Journal of translational medicine
|July 14, 2023
概括
小细胞肺癌 (SCLC) 的治疗正在超越化疗. 新的向疗法和免疫检查点抑制剂显示出有前途,以及针对个性化SCLC治疗策略的多种omics.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 精准医学是一门精准的医学.
背景情况:
- 小细胞肺癌 (SCLC) 由于其侵略性,不良预后和化学抵抗的发展而构成重大挑战.
- 基于的化疗仍然是标准治疗方法,但其长期疗效受到获得的耐药性限制.
研究的目的:
- 审查SCLC治疗的最新进展,重点关注新型分子标和免疫疗法.
- 探索精准医学的作用,包括多组的亚型化,在量身定制SCLC治疗.
- 讨论增强免疫检查点抑制剂疗效和确定预测生物标志物的策略.
主要方法:
- 关于SCLC向疗法,免疫检查点抑制剂和多种omics方法的最近研究的文献综述.
- 对新兴分子标的分析,如ATR,WEE1,CHK1和PARP抑制剂.
- 讨论早期检测和多维预后模型的预测建模.
主要成果:
- 涉及ATR,WEE1,CHK1和PARP的向疗法显示出用于SCLC治疗的潜力.
- 免疫检查点抑制剂 (ICI) 是至关重要的,但优化它们的使用需要进一步研究有效性增强,毒性降低和生物标志物选择.
- 多omics亚型越来越多地用于SCLC的个性化治疗策略.
结论:
- 在通过向疗法和免疫疗法治疗SCLC方面取得了显著进展.
- 精准医学方法,包括多奥米,对于改善SCLC患者的治疗结果至关重要.
- 需要进一步的研究来完善早期检测和预后的预测模型,以实现精确的SCLC治疗.
更多相关视频
10:29Semi-automatic PD-L1 Characterization and Enumeration of Circulating Tumor Cells from Non-small Cell Lung Cancer Patients by Immunofluorescence
Published on: August 14, 2019
10.6K
07:42Patient-Derived Tumor Explants As a "Live" Preclinical Platform for Predicting Drug Resistance in Patients
Published on: February 7, 2021
5.0K
相关概念视频
02:57Targeted Cancer Therapies
7.7K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.7K
02:50Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
02:56Treatment Resistant Cancers
3.3K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.3K
02:49Cancer Therapies
7.7K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.7K